{
    "2018-08-17": [
        [
            {
                "time": "",
                "original_text": "[快讯]沃森生物公布半年报 净利润同比增减270.08%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "半年报",
                        "净利润",
                        "同比增减",
                        "270.08%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：上半年子公司百白破疫苗批签发量同比增15倍",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "子公司",
                        "百白破疫苗",
                        "批签发量",
                        "同比增",
                        "15倍"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}